ophthalmic agent (eyedrops)
Jump to navigation
Jump to search
Introduction
Pharmaceutical agent used in or on the eye.
Dosage
- each eye only holds one drop
- a 2nd drop will only wash out the 1st
- close your eyes for 2-3 minutes after eyedrop
Adverse effects
- uveitis[3]
- prostaglandin analogs (0.32%) < alpha adrenergic agonists (1.63%) < carbonic anhydrase inhibitors (1.68%) < beta-blockers (1.95%)
Notes
- instructions & tips on how to use eyedrops[2]
- includes video
More general terms
More specific terms
- aceclidine (Vizz)
- acoltremon (Tryptyr)
- aflibercept ophthalmic (Eylea)
- apraclonidine ophthalmic (Iopidine)
- avacincaptad pegol (Izeray)
- bevacizumab ophthalmic (Avastin)
- brinzolamide (Azopt)
- cenegermin; cenegermin-bkbj (Oxervate, Sentinel)
- ciclosporin ophthalmic; cyclosporine A ophthalmic (Restasis, Cequa)
- cycloplegic agent
- dipivefrin ophthalmic (Propine)
- faricimab-svoa (Vabysmo)
- fomivirsen (Vitravene)
- latanoprostene BUNOD (Vyzulta)
- lenadogene nolparvovec (Lumevoq)
- lifitegrast (Xiidra)
- microplasmin ophthalmic
- miotic agent
- mydriatic agent
- netarsudil (Rhopressa)
- ocriplasmin ophthalmic (Jetrea)
- ocular decongestant
- ophthalmic anesthetic
- ophthalmic anti-inflammatory agnet
- ophthalmic antibiotic
- ophthalmic irrigation solution; eye wash
- oxyphenbutazone
- pegaptanib ophthalmic (Macugen)
- pegcetacoplan (Empaveli, Syfovre)
- perfluorohexyloctane (Miebo)
- polyvinyl alcohol ophthalmic (artificial tears, Lacril, Tears Naturale, Tears Plus, Hypotears, Lacrilube, GenTeal, Refresh Tears)
- propylene glycol ophthalmic (Systane Balance)
- ranibizumab ophthalmic (Lucentis, Byooviz)
- riboflavin-5'-phosphate (Photrexa)
- serum eye drops
- tafluprost ophthalmic (Zioptan)
- UBX1325
References
- ↑ Prescriber's Letter 17(3): 2010 PATIENT HANDOUT: How to Use Eyedrops COMMENTARY: Systemic Effects of Ophthalmic Beta-Blockers PATIENT HANDOUT SPANISH VERSION: Como usar las gotas para los ojos Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=260309&pb=PRL (subscription needed) http://www.prescribersletter.com
- ↑ 2.0 2.1 Glaucoma Research Foundation: Eye Drop Tips http://www.glaucoma.org/treatment/eyedrop-tips.php
- ↑ 3.0 3.1 Chauhan MZ, Elhusseiny AM, Marwah S et al Incidence of Uveitis Following Initiation of Prostaglandin Analogs versus Other Glaucoma Medications: A Study from the Sight Outcomes Research Collaborative Repository. Ophthalmol Glaucoma. 2025 Mar-Apr;8(2):126-132. PMID: https://pubmed.ncbi.nlm.nih.gov/39542214 PMCID: PMC11930623 (available on 2026-03-01)